Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today announced that the RELIEVE UCCD phase 2b study met its primary endpoints in patients with ulcerative ...

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn's disease Primary endpoints met in ulcerative colitis (UC) and Crohn's disease (CD), the most ...

Phase 2 results in inflammatory bowel disease hinted the therapy could be more potent than similar medicines from Merck and ...

A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM ...

A complex, chronic, and debilitating condition, inflammatory bowel disease (IBD) affects roughly 3 million Americans, including those with Crohn's disease and ulcerative colitis.

Crohn’s & Colitis UK are delighted to be awarded a grant of $638,000 from The Leona M. and Harry B. Helmsley Charitable Trust ...

Crohn’s and Ulcerative colitis can start at any age, but usually symptoms start before the age of 30. Microscopic Colitis is more common in women and usually starts after 50. Crohn’s and Colitis ...

Abby's interest in nursing started with her own experience with illness. She was diagnosed at 15 years with Ulcerative ...

Discover how β-ionone offers relief from ulcerative colitis by enhancing gut health, reducing inflammation, and restoring ...

The research demonstrates that β-ionone can alleviate UC symptoms in mice by protecting the gut barrier and restoring the gut ...